Attached files

file filename
10-Q - QUARTERLY REPORT - MusclePharm Corpv228247_10q.htm
EX-3.1 - CERTIFICATE OF DESIGNATION - MusclePharm Corpv228247_ex3-1.htm
EX-10.2 - EMPLOYMENT AGREEMENT - MusclePharm Corpv228247_ex10-2.htm
EX-32.1 - CERTIFICATION - MusclePharm Corpv228247_ex32-1.htm
EX-31.2 - CERTIFICATION - MusclePharm Corpv228247_ex31-2.htm
EX-31.1 - CERTIFICATION - MusclePharm Corpv228247_ex31-1.htm
EX-10.1 - EMPLOYMENT AGREEMENT - MusclePharm Corpv228247_ex10-1.htm
CERTIFICATION PURSUANT TO
18 U.S.C. SECTION 1350,
AS ADOPTED PURSUANT TO SECTION 906 OF
THE SARBANES-OXLEY ACT OF 2002

In connection with this Quarterly Report of MusclePharm Corporation (the “Company”), on Form 10-Q for the quarter ended June 30, 2011, as filed with the U.S. Securities and Exchange Commission on the date hereof, I, Lawrence S. Meer, Principal Financial Officer of the Company, certify to the best of my knowledge, pursuant to 18 U.S.C. Sec. 1350, as adopted pursuant to Sec. 906 of the Sarbanes-Oxley Act of 2002, that:

(1)  
Such Quarterly Report on Form 10-Q for the quarter ended June 30, 2011, fully complies with the requirements of section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

(2)  
The information contained in such Quarterly Report on Form 10-Q for the quarter ended June 30, 2011, fairly presents, in all material respects, the financial condition and results of operations of the Company.
 
       
Date: August 16, 2011
By:
/s/ Lawrence S. Meer
 
   
Lawrence S. Meer
 
   
Principal Accounting Officer
MusclePharm Corporation